OTC : AONC
$2 (20.0%)
14
5
$4.11M
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Valle William | director | 2024-07-16 | A-Award | 0 | 2024-07-18 |
| Fluegel Bradley M | director | 2024-07-16 | A-Award | 0 | 2024-07-18 |
| Divers Stephen | director, officer: Chief Medical Officer | 2024-07-16 | A-Award | 0 | 2024-07-18 |
| Mallon Erica | officer: General Counsel | 2024-07-16 | A-Award | 0 | 2024-07-18 |
| Afshar David | officer: Chief Financial Officer | 2024-07-16 | A-Award | 0 | 2024-07-18 |
| Schonherz Todd | director, officer: Chief Executive Officer | 2024-07-16 | A-Award | 0 | 2024-07-18 |
| Afshar David | officer | 2024-06-03 | 0 | 2024-06-13 | |
| Divers Stephen | director, officer: Chief Medical Officer | 2024-05-24 | P-Purchase | 2.15 | 2024-05-30 |
| Schonherz Todd | director, officer: Chief Executive Officer | 2024-05-21 | P-Purchase | 1.86 | 2024-05-30 |
| Schonherz Todd | director, officer: Chief Executive Officer | 2024-05-21 | P-Purchase | 1.85 | 2024-05-30 |
| Schonherz Todd | director, officer: Chief Executive Officer | 2024-05-21 | P-Purchase | 1.87 | 2024-05-30 |
| Fluegel Bradley M | director | 2024-05-04 | A-Award | 0 | 2024-05-07 |
| Valle William | director | 2024-05-04 | A-Award | 0 | 2024-05-07 |
| Valle William | director: | 2024-04-19 | 0 | 2024-04-29 | |
| Divers Stephen | director, officer: Chief Medical Officer | 2024-03-20 | F-InKind | 5.7 | 2024-03-22 |
| Divers Stephen | director, officer: Chief Medical Officer | 2024-03-19 | A-Award | 5.69 | 2024-03-20 |
| Divers Stephen | director, officer: Chief Medical Officer | 2024-01-05 | F-InKind | 6.1 | 2024-01-22 |
| Divers Stephen | director, officer: Chief Medical Officer | 2023-09-20 | 0 | 2024-01-22 | |
| Divers Stephen | director, officer: Chief Medical Officer | 2023-09-20 | 0 | 2024-01-22 | |
| Divers Stephen | director, officer: Chief Medical Officer | 2023-09-20 | 0 | 2024-01-22 | |
| Divers Stephen | director, officer: Chief Medical Officer | 2024-01-05 | F-InKind | 6.1 | 2024-01-08 |
| Divers Stephen | director, officer: Chief Medical Officer | 2024-01-03 | A-Award | 0 | 2024-01-08 |
| HealthQuest Tactical Opportunities Fund, L.P. | 10 percent owner | 2023-10-30 | 10 | 2023-11-09 | |
| HealthQuest Tactical Opportunities Fund, L.P. | 10 percent owner | 2023-10-30 | 10 | 2023-11-09 | |
| HealthQuest Tactical Opportunities Fund, L.P. | 10 percent owner | 2023-10-30 | 10 | 2023-11-09 | |
| Digital Transformation Sponsor LLC | 10 percent owner | 2023-09-20 | J-Other | 0 | 2023-09-29 |
| Saba Capital Management, L.P. | 10 percent owner | 2023-09-25 | S-Sale | 10.5 | 2023-09-25 |
| AEA GROWTH EQUITY FUND LP | 10 percent owner | 2023-09-20 | A-Award | 10 | 2023-09-22 |
| AEA GROWTH EQUITY FUND LP | 10 percent owner | 2023-09-20 | A-Award | 10 | 2023-09-22 |
| AEA GROWTH EQUITY FUND LP | 10 percent owner: | 2023-09-20 | 0 | 2023-09-22 | |
| Digital Transformation Sponsor LLC | 10 percent owner | 2023-09-20 | J-Other | 0 | 2023-09-20 |
| Digital Transformation Sponsor LLC | 10 percent owner | 2023-09-20 | J-Other | 11.5 | 2023-09-20 |
| Fluegel Bradley M | director | 2023-09-20 | J-Other | 0 | 2023-09-20 |
| Wright-Browne Vance | director | 2023-09-20 | 0 | 2023-09-20 | |
| Stith James | director: | 2023-09-20 | 0 | 2023-09-20 | |
| Shah Shalin | director | 2023-09-20 | 0 | 2023-09-20 | |
| Schonherz Todd | director, officer: Chief Executive Officer | 2023-09-20 | 0 | 2023-09-20 | |
| SARIN RAVI YANG | director: | 2023-09-20 | 0 | 2023-09-20 | |
| Patel Vipul M | director | 2023-09-20 | 0 | 2023-09-20 | |
| Mallon Erica | officer | 2023-09-20 | 0 | 2023-09-20 | |
| Gould David H | officer | 2023-09-20 | 0 | 2023-09-20 | |
| Divers Stephen | director, officer: Chief Medical Officer | 2023-09-20 | 0 | 2023-09-20 | |
| Divers Stephen | director, officer: Chief Medical Officer | 2023-09-20 | 0 | 2023-09-20 | |
| Francis Kyle | officer: Chief Financial Officer | 2021-03-09 | 0 | 2021-03-10 | |
| Zynczak Heather | director | 2021-03-09 | 0 | 2021-03-09 |